Literature DB >> 31470000

Glaucoma and Cornea Surgery Outcomes in Peters Anomaly.

Kara A Dolezal1, Cagri G Besirli2, Shahzad I Mian2, Alan Sugar2, Sayoko E Moroi2, Brenda L Bohnsack3.   

Abstract

PURPOSE: To conduct a qualitative description of corneal and glaucoma outcomes in Peters anomaly.
DESIGN: Retrospective case series.
METHODS: Children with Peters anomaly who presented between 1982-2017 were included. Visual acuity, intraocular pressure (IOP), survival of corneal grafts, and success of glaucoma surgery (defined as IOP of 5-20 mm Hg and no additional IOP-lowering surgery or visually devastating complications) were analyzed.
RESULTS: Fifty-eight eyes of 37 patients (19 males) with Peters anomaly presented at 0.7 ± 1.5 years of age and had a follow-up of 10.2 ± 10.8 years. Twenty-three eyes underwent penetrating keratoplasty (PKP) with an average of 2.0 ± 1.3 grafts per eye. PKP survival at 1 year was 60% (95% confidence interval 41-75%) but decreased at 10 years to 34% (95% confidence interval 18-51%). Thirty-four eyes were diagnosed with glaucoma at 2.8 ± 6.4 years of age. Twenty eyes required glaucoma surgery, and the average number of IOP-lowering surgeries was 2.9 ± 2.0 per eye. Glaucoma drainage devices (15 eyes) had a 53% success rate. Laser cycloablation (9 eyes, transcleral or endoscopic) had a success rate of 67% with 2.0 ± 1.0 treatments per eye. Trabeculectomy with mitomycin C (8 eyes) and trabeculotomy (8 eyes) had 25% and 0% success rates, respectively. Fifteen eyes that underwent glaucoma surgery obtained IOP control, and GDD with or without cycloablation accounted for 80% of the successes. Eyes that underwent PKP did not show increased rates of glaucoma, higher IOP, or a greater necessity for IOP-lowering surgery.
CONCLUSIONS: In Peters anomaly, PKP shows poor long-term success. In addition, >50% of eyes with Peters anomaly have secondary glaucoma that often requires multiple surgeries.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31470000     DOI: 10.1016/j.ajo.2019.08.012

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Ologen augmentation of Ahmed glaucoma drainage devices in pediatric glaucomas.

Authors:  Adam Jacobson; Carin Rojas; Brenda L Bohnsack
Journal:  BMC Ophthalmol       Date:  2021-02-05       Impact factor: 2.209

2.  Outcomes of combined endoscopic vitrectomy and posteriorly placed glaucoma drainage devices in pediatric patients.

Authors:  A Jacobson; C G Besirli; B L Bohnsack
Journal:  BMC Ophthalmol       Date:  2022-04-01       Impact factor: 2.209

3.  Outcomes of Baerveldt Glaucoma Drainage Devices in Pediatric Eyes.

Authors:  Adam Jacobson; Cagri G Besirli; Brenda L Bohnsack
Journal:  J Glaucoma       Date:  2021-12-21       Impact factor: 2.290

4.  Selective endothelial removal: A case series of a phase I/II surgical trial with long-term follow up.

Authors:  Yu-Chi Liu; Yu Qiang Soh; Viridiana Kocaba; Jodhbir S Mehta
Journal:  Front Med (Lausanne)       Date:  2022-07-29

5.  Visual Outcomes in Pediatric Patients with Peters Anomaly.

Authors:  Samiksha Fouzdar-Jain; Zena Ibrahim; Jeremy Reitinger; Dingcai Cao; Mehmet C Mocan
Journal:  Clin Ophthalmol       Date:  2021-06-18

Review 6.  Glaucoma Syndromes: Insights into Glaucoma Genetics and Pathogenesis from Monogenic Syndromic Disorders.

Authors:  Daniel A Balikov; Adam Jacobson; Lev Prasov
Journal:  Genes (Basel)       Date:  2021-09-11       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.